Winshine Science Company Limited (Stock Code: 00209) released its monthly return for the period ended 31 January 2026. According to the announcement, the total authorised share capital remains at 70,000,000,000 ordinary shares with a par value of HKD 0.01 each, amounting to HKD 700,000,000 in total.
The number of issued shares (excluding treasury shares) increased from 185,708,976 to 1,485,671,808. This increase of 1,299,962,832 issued shares stemmed primarily from a rights issue at HKD 0.14 per share that took effect on 16 January 2026, following an earlier general meeting approval on 5 December 2025.
The company confirmed that its public float requirement, as stipulated by relevant rules, has been complied with. No share options were exercised during the month under review, and there were no outstanding warrants or other convertible instruments. The statement was submitted by the Company Secretary on 3 February 2026.